Details
Tirzepatide (10mg) – Dual GIP/GLP-1 Receptor Agonist
Advance metabolic research with Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Designed exclusively for laboratory, empirical, and in-vitro research applications, Tirzepatide is extensively investigated for its role in dual incretin signaling, glycemic kinetics, and cellular metabolic pathway modeling.
Research Properties & Applications
Key Research Properties:
- Dual Incretin Activation: Evaluated for simultaneous affinity at GIP and GLP-1 receptor pathways.
- Metabolic Modeling: Investigated in cellular models studying lipid dynamics and metabolic rate regulation.
- Glycemic Dynamics: Examined in receptor binding assays focused on glucose-dependent signaling and insulin secretion pathways.
- High Purity Standard: Independently 3rd-party laboratory tested to ensure sequence accuracy and chemical purity.
Ideal For:
- In-vitro dual incretin pathway research
- Metabolic pathway signaling and receptor kinetics modeling
- Glycemic control and cellular response studies
- Endocrine system and receptor affinity investigations
Laboratory Reference Protocol
Standard empirical research assays utilize benchmark working concentrations ranging from 2.5 mg to 15 mg per test subject/model interval. Specific working parameters depend on experimental protocol objectives.
Reconstitution Guidance
Add 1mL of sterile bacteriostatic water to achieve a solution of 10mg/mL, such that every 0.1mL (10 units on a standard syringe) is equal to 1mg of Tirzepatide.
Storage & Compliance Disclaimer
Storage: Store unmixed lyophilized vials in a cool, dark environment away from direct light. Once reconstituted, store under refrigeration between 2°C – 8°C (36°F – 46°F) and use within 30 days.
Disclaimer: This product is sold strictly as a laboratory research chemical and is not intended for human or animal consumption, medical, diagnostic, or therapeutic use.
